The Impact of Medications on Quality of Life in Attention-Deficit Hyperactivity Disorder: A Systematic Review

By Coghill David  

CNS Drugs, Vol. 24, Iss. 10, 2010-10 ,pp. : 843-866

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder in Adults

By Santosh Paramala J.   Sattar Sanjida  

CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. : 737-763

Adis International

Access to resources Recommend Favorite

Adverse Effects of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder: Epidemiology, Prevention and Management

By Graham Johnny   Coghill David  

CNS Drugs, Vol. 22, Iss. 3, 2008-01 ,pp. : 213-237

Adis International

Access to resources Recommend Favorite

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

By Peterson Kim   McDonagh Marian   Fu Rongwei  

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Atomoxetine: A Review of its Use in Attention-Deficit Hyperactivity Disorder in Children and Adolescents

By Garnock-Jones Karly P.   Keating Gillian M.  

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 203-226

Adis International

Access to resources Recommend Favorite